Physician profile
Robert A Youkilis
NPI 1508814740
$861.19
in general payments reported to CMS, 2019-2025
16 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $75.61 · 2021: $8.67 · 2022: $103 · 2023: $83.08 · 2024: $21.29 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $260.99 | 2019 | |
| Optinose US, INC. | $137.56 | 2019-2022 | |
| Acclarent, INC | $98.82 | 2019-2022 | |
| Inspire Medical Systems, INC. | $83.08 | 2023 | Inspire |
| Aerin Medical INC. | $49.57 | 2025 | |
| Glaxosmithkline, LLC. | $45.70 | 2022-2025 | Nucala |
| Shire North American Group INC | $26.97 | 2019 | |
| Integra Lifesciences Corporation | $22.13 | 2019 | |
| Precigen, INC. | $22.11 | 2025 | |
| Masimo Corporation | $21.29 | 2024 | Set and Rainbow Set |
| Ethicon US, LLC | $19.17 | 2019 | |
| Genzyme Corporation | $18.58 | 2025 | |
| Kaleo, INC. | $16.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.72 | 2020 | |
| Olympus America INC. | $12.94 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Youkilis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.